Find your path to Paul
252 people in our graph share verified history with Paul — schools, employers, funds. One of them is your warm intro.
Derek SatherunlockedPaul: together at MIT Sloan School of Management (2015–2016)
×7Paul: together at MIT Sloan School of Management
×2Paul: together at Mediar Therapeutics
×2Paul: together at RA Capital
About
Paul Yaworsky is President at Kilmer Capital Partners Limited. His background includes mergers and acquisitions, operations, and finance, with experience in transaction sourcing, structuring, negotiations, due diligence, business turnarounds, restructurings, integrations, and divestitures. He holds an MBA and Chartered Professional Accountant (CPA) and Certified Management Accountant (CMA) designations.
CSO at Mediar Therapeutics
Intro paths
→
In turn, Paul can intro founders to Mediar Therapeutics's investors below.
Mediar Therapeutics's investors · 9
Agent CapitalWalthamLongwood FundBoston · since 2026Mission BiocapitalSan Francisco · $500K checks · since 2025Novartis Venture FundBasel · $5M – $25M checks · since 2022Ono Venture Investment, Inc.South San FranciscoPfizer Venture Investments$5M – $20M checksPfizer VenturesShangBay Capital LLCPalo AltoSofinnova PartnersParis · $540K – $27M checks · since 2025
Experience
- Raven Healthcare Incubator (RA Capital)Venture Partnercurrent2026 — presentBoston, Massachusetts, United States
- Mediar TherapeuticsScientific Advisorcurrent2026 — presentBoston, Massachusetts, United States
- Mediar TherapeuticsChief Scientific Officer2019 — 2026Boston, Massachusetts, United States
- Three Lakes 12-20Advisory Board Membercurrent2025 — present
- WEST - Women in the Enterprise of Science and TechnologyAdvisory Board Member2023 — 2025
- PfizerChief Operating Officer, Inflammation & Immunology Research2012 — 2019Cambridge, MA
- PfizerDirector, Inflammation & Remodeling Research, Fibrosis Disease Area Lead2011 — 2012Cambridge, MA
- PfizerDirector, Tissue Repair Research2010 — 2011Cambridge, MA
- PfizerAssociate Director, Muscle Research, Women's Health & Musculoskeletal Biology (Wyeth)2006 — 2009Cambridge, MA
- PfizerPrincipal Scientist II, Biological Technologies (Wyeth)2006Cambridge, MA
- PfizerPrincipal Scientist I, Biological Technologies (Wyeth)2002 — 2005Cambridge, MA
- PfizerStaff Scientist II, Genomics (Wyeth)2001 — 2002Cambridge, MA
- PfizerStaff Scientist I, Genomics (Wyeth)1999 — 2000Cambridge, MA
- PfizerPostdoctoral Fellow (Genetics Institute)1998 — 1999Cambridge, MA
Skills & more
Drug Discovery52Drug Development40Biotechnology32Life Sciences30Biomarkers24Immunology26Assay Development16Clinical Development15Molecular Biology13Genomics9Inflammation11Translational Medicine5
+10 more
AntibodiesOncologyBiopharmaceuticalsCell CultureCellProtein ChemistryPharmacologyMonoclonal AntibodiesStrategyPharmaceutical IndustryFrom Paul's professional profile.
Colleagues at RA Capital
Abigail Schmitz
Senior Associate, Corporate Development at RA Capital
Adam Kaye
Senior Managing Director and Partner, Structured Capital at RA Capital
Adrian Bot
Venture Partner at RA Capital
Albert Kim
Advisor at RA Capital
Alex Miller
Senior Associate, Venture at RA Capital
Alex Zhang
Vice President, Structured Capital at RA Capital
Alison Tisdale
Advisor at RA Capital
Alyssa Larson
Investor at RA Capital
Frequently asked questions
- Who is Paul Yaworsky?
- Paul Yaworsky is President at Kilmer Capital Partners Limited. His background includes mergers and acquisitions, operations, and finance, with experience in transaction sourcing, structuring, negotiations, due diligence, business turnarounds, restructurings, integrations, and divestitures. He holds an MBA and Chartered Professional Accountant (CPA) and Certified Management Accountant (CMA) designations.
- Where does Paul Yaworsky work?
- Paul Yaworsky is Venture Partner at RA Capital and CSO at Mediar Therapeutics.
- Where did Paul Yaworsky go to school?
- Paul Yaworsky studied at MIT Sloan School of Management (Certificate, Strategy and Innovation); Mayo Clinic Graduate School of Biomedical Sciences (PhD, Molecular Neuroscience); University of Toronto - University College (BSc, Molecular Genetics).
Same school
Also attended MIT Sloan School of Management936
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOlaInvestor at Investinor
+ 930 more
Also attended Mayo Clinic Graduate School of Biomedical Sciences4
Also attended University of Toronto - University College9
Frederik GroenewegenGeneral Partner at 415 CapitalAlan SalzmanCEO and Managing Partner at VantagePoint Capital PartnersJessica PalterChief Legal Officer at Purpose InvestmentsTihomir BajicManaging Partner, X& at Leaders FundMark TerrillPeer Forum Facilitator at InterGen CapitalRyan HenryPartner at Sand Hill North Ventures
+ 3 more
Shared employers
Also worked at Raven Healthcare Incubator (RA Capital)10
Peyman HosseinchiSenior Associate at JDRF T1D FundJames StankowiczHead of AI & Engineering at Luma GroupJosh ResnickPartner at RA CapitalRamin Farzaneh-FarVenture Partner at RA CapitalJonathan HillEntrepreneur-In-Residence at RA CapitalGerald SewackVenture Partner at RA Capital
+ 4 more
Also worked at Mediar Therapeutics12
Adam CottonPrincipal at the Novartis Venture FundAnja KoenigGlobal Head of NVF at Novartis Venture FundOliver WalkerManaging Partner at CGS Management AGAnja KönigGlobal Head at Novartis Venture FundChristoph KocherPrincipal at GimvAndreas JurgeitPartner at Gimv
+ 6 more
Also worked at WEST - Women in the Enterprise of Science and Technology4
Also worked at Pfizer402
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital
+ 396 more